A novel 3D method of locomotor analysis in adult zebrafish: Implications for automated detection of CNS drug-evoked phenotypes

Journal of Neuroscience Methods

Volumn 255, Issue , 2015, Pages 66-74

  Stewart, Adam Michael ^a,b   Grieco, Fabrizio ^c   Tegelenbosch, Ruud A J ^c   Kyzar, Evan J ^d   Nguyen, Michael ^a,b   Kaluyeva, Aleksandra ^a,b   Song, Cai ^e,f   Noldus, Lucas P J J ^b,c   Kalueff, Allan V ^e,g,h  

^a ZENEREI Institute   (United States)

^b ZENEREI Institute ZNRC   (United States)

^c Noldus Information Technology bv   (Netherlands)

^d UNIVERSITY OF ILLINOIS   (United States)

^e GUANGDONG OCEAN UNIVERSITY   (China)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^h URAL FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

Drug discovery; High throughput screening; Neurophenotype; Video tracking; Zebrafish

Indexed keywords

LYSERGIDE; NICOTINE; PHENCYCLIDINE; NICOTINE VACCINE; PSYCHOTROPIC AGENT; VACCINE;

ADULT; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; AUTOMATION; BEHAVIOR ASSESSMENT; COMPUTER PROGRAM; CONTROLLED STUDY; DATA MINING; FEMALE; HIGH THROUGHPUT SCREENING; LOCOMOTION; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SWIMMING; VIDEORECORDING; ZEBRA FISH; ACCELEROMETRY; ANIMAL; AUTOMATED PATTERN RECOGNITION; BIOMECHANICS; COMPARATIVE STUDY; DEVICES; DRUG DEVELOPMENT; DRUG EFFECTS; EQUIPMENT DESIGN; MOTOR ACTIVITY; PHYSIOLOGY; PROCEDURES; VALIDATION STUDY;

ACCELEROMETRY; ANIMALS; BIOMECHANICAL PHENOMENA; DRUG DISCOVERY; EQUIPMENT DESIGN; FEMALE; LYSERGIC ACID DIETHYLAMIDE; MALE; MOTOR ACTIVITY; PATTERN RECOGNITION, AUTOMATED; PHENCYCLIDINE; PHENOTYPE; PSYCHOTROPIC DRUGS; SOFTWARE; SWIMMING; VACCINES; VIDEO RECORDING; ZEBRAFISH;

EID: 84941768968     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2015.07.023     Document Type: Article

References (81)

1. Agid Y., Buzsáki G., Diamond D.M., Frackowiak R., Giedd J., Girault J.-A., et al. How can drug discovery for psychiatric disorders be improved?. Nat Rev Drug Discovery 2007, 6:189-201.
2. Bandmann O., Burton E.A. Genetic zebrafish models of neurodegenerative diseases. Neurobiol Dis 2010, 40:58-65.
3. Becker T.S., Rinkwitz S. Zebrafish as a genomics model for human neurological and polygenic disorders. Dev Neurobiol 2012, 72:415-428.
4. Blaser R.E., Rosemberg D.B. Measures of anxiety in Zebrafish (Danio rerio): dissociation of Black/White Preference and Novel Tank Test. PLoS ONE 2012, 7:e36931.
5. Bruni G., Lakhani P., Kokel D. Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish. Front Pharmacol 2014, 5:153.
6. Burne T., Scott E., van Swinderen B., Hilliard M., Reinhard J., Claudianos C., et al. Big ideas for small brains: what can psychiatry learn from worms, flies, bees and fish?. Mol Psychiatry 2010, 16:7-16.
7. Cachat J., Kyzar E.J., Collins C., Gaikwad S., Green J., Roth A., et al. Unique and potent effects of acute ibogaine on zebrafish: the developing utility of novel aquatic models for hallucinogenic drug research. Behav Brain Res 2013, 236:258-269.
8. Cachat J., Stewart A., Utterback E., Hart P., Gaikwad S., Wong K., et al. Three-dimensional neurophenotyping of adult zebrafish behavior. PLoS ONE 2011, 6:e17597.
9. Cachat J.M. Developing zebrafish models of complex phenotypes relevant to human brain disorders. Neuroscience 2013, 150. Tulane University, New Orleans, LA.
10. Cachat J.M., Canavello P., Elegante M.F., Bartels B., Hart P., Bergner C., et al. Modeling withdrawal syndrome in zebrafish. Behav Brain Res 2010, 208:371-376.
11. Cachat J.M., Stewart A., Grossman L., Gaikwad S., Kadri F., Chung K.M., et al. Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nat Protoc 2010, 5:1786-1799.
12. Cachat J.M., Stewart A., Utterback E., Hart P., Gaikwad S., Wong K., et al. Three-dimensional neurophenotyping of adult zebrafish behavior. PLoS ONE 2011, 6:e17597.
13. Champagne D.L., Hoefnagels C.C.M., de Kloet R.E., Richardson M.K. Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research. Behav Brain Res 2010, 214:332-342.
14. Cressey D. Psychopharmacology in crisis. Nature 2011, 10.1038/news.2011.367.
15. Echevarria D.J., Jouandot D.J., Toms C.N. Assessing attention in the zebrafish. Progr Neuropsychopharmacol Biol Psychiatry 2011, 35:1416-1420.
16. Egan R.J., Bergner C.L., Hart P.C., Cachat J.M., Canavello P.R., Elegante M.F., et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 2009, 205:38-44.
17. Fleming A., Alderton W.K. Zebrafish in pharmaceutical industry research: finding the best fit. Drug Discovery Today: Dis Models 2012, 1-8.
18. Flinn L., Bretaud S., Lo C., Ingham P.W., Bandmann O. Zebrafish as a new animal model for movement disorders. J Neurochem 2008, 106:1991-1997.
19. Gaikwad S., Stewart A., Hart P., Wong K., Piet V., Cachat J.M., et al. Acute stress disrupts performance of zebrafish in the cued and spatial memory tests: the utility of fish models to study stress-memory interplay. Behav Process 2011, 87:224-230.
20. Gama Sosa M.A., De Gasperi R., Elder G.A. Modeling human neurodegenerative diseases in transgenic systems. Human Genet 2012, 131:535-563.
21. Gerlai R. Using zebrafish to unravel the genetics of complex brain disorders. Curr Top Behav Neurosci 2012, 12:3-24.
22. Gerlai G.R. Zebrafish, a potential novel research tool for the analysis and modeling of anxiety. Different views on anxiety disorders 2011, 〈intechopen.com〉. S. Selek (Ed.).
23. Gerlai R., Lahav M., Guo S., Rosenthal A. Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 2000, 67:773-782.
24. Gómez-Laplaza L.M., Gerlai R. Latent learning in zebrafish (Danio rerio). Behav Brain Res 2010, 208:509-515.
25. Gould G.G. Modified associative learning T-maze test for zebrafish (Danio rerio) and other small teleost fish. Zebrafish neurobehavioral protocols, neuromethods 2011, 61-74. A.V. Kalueff, J. Cachat (Eds.).
26. Green J., Collins C., Kyzar E.J., Pham M., Roth A., Gaikwad S., et al. Automated high-throughput neurophenotyping of zebrafish social behavior. J Neurosci Methods 2012, 210:266-271.
27. Grossman L., Utterback E., Stewart A., Gaikwad S., Chung K.M., Suciu C., et al. Characterization of behavioral and endocrine effects of LSD on zebrafish. Behav Brain Res 2010, 214:277-284.
28. Guo S., Wagle M., Mathur P. Toward molecular genetic dissection of neural circuits for emotional and motivational behaviors. Dev Neurobiol 2011.
29. Ingham P.W. The power of the zebrafish for disease analysis. Hum Mol Gen 2009, 18:R107-R112.
30. Jesuthasan S. Fear anxiety, and control in the zebrafish. Dev Neurobiol 2012, 72:395-403.
31. Kabashi E., Brustein E., Champagne N., Drapeau P. Zebrafish models for the functional genomics of neurogenetic disorders. BBA-Mol Basis Dis 2011, 1812:335-345.
32. Kabashi E., Champagne N., Brustein E., Drapeau P. In the swim of things: recent insights to neurogenetic disorders from zebrafish. Trends Genet 2010, 26:373-381.
33. Kalueff A.V., Gebhardt M., Stewart A.M., Cachat J.M., Brimmer M., Chawla J.S., et al. Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish 2013, 10:70-86.
34. Kokel D., Bryan J., Laggner C., White R., Cheung C.Y.J., Mateus R., et al. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol 2010, 6:231-237.
35. Kokel D., Peterson R.T. Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish. Brief Funct Genomics Proteomics 2008, 7:483-490.
36. Kokel D., Peterson R.T. Using the zebrafish photomotor response for psychotropic drug screening. Methods Cell Biol 2011, 105:517-524.
37. Kokel D., Rennekamp A.J., Shah A.H., Liebel U., Peterson R.T. Behavioral barcoding in the cloud: embracing data-intensive digital phenotyping in neuropharmacology. Trends Biotechnol 2012, 1-5.
38. Kokel D., Rennekamp A.J., Shah A.H., Liebel U., Peterson R.T. Behavioral barcoding in the cloud: embracing data-intensive digital phenotyping in neuropharmacology. Trends Biotechnol 2012, 30:421-425.
39. Kyzar E.J., Collins C., Gaikwad S., Green J., Roth A., Monnig L., et al. Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology. Prog Neuropsychopharmacol Biol Psychiatry 2012, 37:194-202.
40. Lessman C.A. The developing zebrafish (Danio rerio): a vertebrate model for high-throughput screening of chemical libraries. Birth Defects Res, C: Embryo Today: Rev 2011, 93:268-280.
41. Lillesaar C. The serotonergic system in fish. J Chem Neuroanat 2011, 41:294-308.
42. Liu Y., Lee S.-H., Chon T.-S. Analysis of behavioral changes of zebrafish (Danio rerio) in response to formaldehyde using Self-organizing map and a hidden Markov model. Ecol Modell 2011, 222:2191-2201.
43. Luca R.M., Gerlai R. In search of optimal fear inducing stimuli: differential behavioral responses to computer animated images in zebrafish. Behav Brain Res 2012, 226:66-76.
44. Maaswinkel H., Zhu L., Weng W. Using an automated 3D-tracking system to record individual shoals of adult zebrafish. J Visual Exp: JoVE 2013, 50681.
45. Marcotte E.R., Pearson D.M., Srivastava L.K., Animal models of schizophrenia: a critical review J Psychiatry Neurosci: JPN 2001, 26:395-410.
46. Markou A., Chiamulera C., Geyer M.A., Tricklebank M., Steckler T. Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacology 2008, 34:74-89. official publication of the American College of Neuropsychopharmacology.
47. Mathur P., Guo S. Differences of acute versus chronic ethanol exposure on anxiety-like behavioral responses in zebrafish. Behav Brain Res 2011, 219:234-239.
48. Mathur P., Guo S. Use of zebrafish as a model to understand mechanisms of addiction and complex neurobehavioral phenotypes. Neurobiol Dis 2010, 40:66-72.
49. Mathur P., Lau B., Guo S. Conditioned place preference behavior in zebrafish. Nat Protoc 2011, 6:338-345.
50. Maximino C., da Silva A.W., Araujo J., Lima M.G., Miranda V., Puty B., et al. Fingerprinting of psychoactive drugs in zebrafish anxiety-like behaviors. PLoS ONE 2014, 9:e431039.
51. Maximino C., de Brito T.M., Colmanetti R., Pontes A.A.A., de Castro H.M., de Lacerda R.I.T., et al. Parametric analyses of anxiety in zebrafish scototaxis. Behav Brain Res 2010, 210:1-7.
52. Meunier R. Stages in the development of a model organism as a platform for mechanistic models in developmental biology: Zebrafish, 1970â€"2000. Stud Hist Philos Biol Biomed Sci 2012, 43:522-531.
53. Neelkantan N., Mikhaylova A., Stewart A.M., Arnold R., Gjeloshi V., Kondaveeti D., et al. Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds. ACS Chem Neurosci 2013, 4:1137-1150.
54. Nguyen M., Stewart A.M., Kalueff A.V. Aquatic blues: modeling depression and antidepressant action in zebrafish. Prog Neuropsychopharmacol Biol Psychiatry 2014.
55. Nguyen M., Yang E., Neelkantan N., Mikhaylova A., Arnold R., Poudel M.K., et al. Developing 'integrative' zebrafish models of behavioral and metabolic disorders. Behav Brain Res 2013, 256:172-187.
56. Norton W., Bally-Cuif L. Adult zebrafish as a model organism for behavioural genetics. BMC Neurosci 2010, 11:90.
57. Panula P., Chen Y.C., Priyadarshini M., Kudo H., Semenova S., Sundvik M., et al. The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 2010, 40:46-57.
58. Panula P., Sallinen V., Sundvik M., Kolehmainen J., Torkko V., Tiittula A., et al. Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases. Zebrafish 2006, 3:235-247.
59. Piato n.L., Capiotti K.M., Tamborski A.R., Oses J.P., Barcellos L.J.G., Bogo M.R., et al. Unpredictable chronic stress model in zebrafish (Danio rerio): behavioral and physiological responses. Progr Neuropsychopharmacol Biol Psychiatry 2011, 35:561-567.
60. Rennekamp A.J., Peterson R.T. From phenotype to mechanism after zebrafish small molecule screens. Drug Discovery Today: Dis Models 2012, 1-5.
61. Rico E.P., Rosemberg D.B., Seibt K.J., Capiotti K.M., Da Silva R.S., Bonan C.D. Zebrafish neurotransmitter systems as potential pharmacological and toxicological targets. Neurotoxicol Teratol 2011, 33:608-617.
62. Riehl R., Kyzar E., Allain A., Green J., Hook M., Monnig L., et al. Behavioral and physiological effects of acute ketamine exposure in adult zebrafish. Neurotoxicol Teratol 2011, 33:658-667.
63. Rihel J., Prober D.A., Arvanites A., Lam K., Zimmerman S., Jang S., et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science (New York N.Y.) 2010, 327:348-351.
64. Rinkwitz S., Mourrain P., Becker T.S., Zebrafish: An integrative system for neurogenomics and neurosciences. Prog Neurobiol 2011, 93:231-243.
65. Rosemberg D.B., Rico E.P., Mussulini B.H., Piato A.L., Calcagnotto M.E., Bonan C.D., et al. Differences in spatio-temporal behavior of zebrafish in the open tank paradigm after a short-period confinement into dark and bright environments. PLoS ONE 2011, 6:e71939.
66. Sallinen V. Zebrafish as a model of Parkinson's disease 2009, 1-111.
67. Savio L.E.B., Vuaden F.C., Piato A.L., Bonan C.D., Wyse A.T.S. Behavioral changes induced by long-term proline exposure are reversed by antipsychotics in zebrafish. Prog Neuro-psychopharmacol Biol Psychiatry 2012, 36:258-263.
68. Soleymani A., Cachat J.M., Robinson K., Dodge S., Kalueff A., Wurbel R. Integrating cross-scale analysis in the spatial and temporal domains for classification of behavioral movement. J Spatial Inform Sci 2014, 8:1-25.
69. Spitzen J., Spoor C., Kranenbarg S. Track3D: visualization and flight track analysis of Anopheles gambiae ss mosquitoes. Proc Measur Behav 2008.
70. Steenbergen P.J., Richardson M.K., Champagne D.L. The use of the zebrafish model in stress research. Progr Neuropsychopharmacol Biol Psychiatry 2011, 35:1432-1451.
71. Stewart A., Riehl R., Wong K., Green J., Cosgrove J., Vollmer K., et al. Behavioral effects of MDMA ('ecstasy') on adult zebrafish. Behav Pharmacol 2011, 22:275-280.
72. Stewart A., Wong K., Cachat J.M., Gaikwad S., Kyzar E., Wu N., et al. Zebrafish models to study drug abuse-related phenotypes. Rev Neurosci 2011, 22:95-105.
73. Stewart A., Wu N., Cachat J., Hart P., Gaikwad S., Wong K., et al. Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:1421-1431.
74. Stewart A., Wu N., Cachat J.M., Hart P., Gaikwad S., Wong K., et al. Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models. Prog Neuro-psychopharmacol Biol Psychiatry 2011, 35:1421-1431.
75. Stewart A.M., Braubach O., Spitsbergen J., Gerlai R., Kalueff A.V. Zebrafish models for translational neuroscience research: from tank to bedside. Trends Neurosci 2014, 37:264-278.
76. Stewart A.M., Gerlai R., Kalueff A.V. Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery. Front Behav Neurosci 2015, 9:14.
77. Stewart A.M., Kalueff A.V. Anxiolytic drug discovery: what are the novel approaches and how can we improve them?. Expert Opin Drug Discovery 2014, 9:15-26.
78. Stewart A.M., Kalueff A.V. Developing better and more valid animal models of brain disorders. Behav Brain Res 2013.
79. Stewart A.M., Nguyen M., Wong K., Poudel M.K., Kalueff A.V. Developing zebrafish models of autism spectrum disorder (ASD). Prog Neuropsychopharmacol Biol Psychiatry 2014, 50:27-36.
80. Tamplin O.J., White R.M., Jing L., Kaufman C.K., Lacadie S.A., Li P., et al. Small molecule screening in zebrafish: swimming in potential drug therapies. Wiley Interdiscip Rev: Dev Biol 2012.
81. van Gerven J., Cohen A. Vanishing clinical psychopharmacology. Br J Clin Pharmacol 2011, 72:1-5.